Quantum-Si stock holds penny level as early 2026 revenue emerges

Quantum-Si stock (ISIN US7491641091) continues to trade at penny levels in September 2026, backed by a market capitalization of USD 159.81 million as of September 18, 2026 and early-stage commercial revenue from its proteomics platform.

Early 2026 figures show initial revenue traction

Quantum-Si Inc. (legal form Inc.) reported revenue of USD 0.602 million for the first half of 2026, marking a modest but tangible step in monetizing its single-molecule protein sequencing technology in the life sciences market, according to an overview dated September 18, 2026 that summarizes the company’s progress in the current year.Ad-hoc-news The same overview classifies the stock as a speculative penny name, emphasizing that the company is still in an early commercialization phase and that its reported revenue remains in the low single-digit million range in fiscal 2026.Ad-hoc-news

The same analysis notes that Quantum-Si is debt-free and holds sufficient cash to finance operations for more than one year, which supports liquidity despite the low share price and helps underpin the company’s ability to continue investing in research, product development and commercialization through at least fiscal 2026.Ad-hoc-news For investors, this combination of low current revenue, no debt and a meaningful cash buffer means that the equity story is driven less by near-term earnings and more by the long-term adoption potential of Quantum-Si’s proteomics platform.

Market view and price targets remain cautious

On the market-intelligence side, Quantum-Si appears with a consensus price target of USD 1.00 in a recent competitive overview, implying a potential upside of 34.21 percent from the stock’s then current trading level and underlining that analysts see some appreciation potential but still only in the very low-dollar range.MarketBeat Price-target data compiled in a separate forecast overview show that analysts collectively expect Quantum-Si’s stock price to reach between USD 1.00 at the low end and USD 4.00 at the high end over the coming period, with the current price described as roughly three-quarters of a dollar.TradingView

Recent trading data from a Nasdaq-focused chart portal put Quantum-Si’s share price at USD 0.7451, down 3.23 percent over the prior 24 hours, with a one-week performance of plus 0.81 percent, a one-month gain of 3.59 percent and a one-year decline of 43.12 percent as of mid-September 2026.TradingView This means that despite small recent gains on a weekly and monthly basis, the stock remains deeply in negative territory on a 12-month view, which fits the classification as a penny stock and reflects persistent investor skepticism about the timing and scale of future revenue growth.

The same chart and forecast resources show that Quantum-Si’s market capitalization stands around USD 163.09 million, only slightly above the USD 159.81 million cited in the broader September 18, 2026 overview, indicating that the company’s equity value has moved only a few million dollars over the most recent trading sessions and underlining how tightly the market currently values the firm around the USD 160 million mark.TradingViewAd-hoc-news In addition, volatility is reported at about 8.31 percent with a beta of 4.04, meaning that Quantum-Si’s stock tends to move much more strongly than the broader market, which amplifies both potential gains and losses for shareholders over short horizons.TradingView

Revenue beats estimates but remains modest

From an earnings perspective, Quantum-Si’s most recent quarterly figures point to revenue of USD 344,000 for the latest reported quarter, compared with an analyst estimate of USD 302,000, meaning the company exceeded expectations by approximately 13.9 percent even though the absolute revenue base remains small.TradingView Forward-looking consensus in the same overview points to expected revenue of USD 280,000 in the next quarter, indicating that analysts currently anticipate a slight sequential decline from the USD 344,000 actually booked in the prior period as the commercialization path remains uneven.TradingView

These numbers illustrate the company’s operating position: Quantum-Si is generating hundreds of thousands of dollars in quarterly revenue and has begun to beat modest consensus expectations, yet the scale of its business is still far from the multi-million or multi-billion levels seen in mature life sciences peers. For investors, the key comparison is that quarterly revenue of USD 344,000 in the latest period and USD 0.602 million over the first half of 2026 together leave the company firmly in an early-stage commercialization phase, where operational execution, cost control and cash runway are more decisive than near-term profitability.TradingViewAd-hoc-news

Stock price and investor perspective

As of September 18, 2026, Quantum-Si shares traded on Nasdaq under the ticker QSI at around USD 0.75, keeping the stock firmly in penny territory and reflecting a one-year decline of more than 40 percent despite small gains over the shorter weekly and monthly horizons.TradingView With a market capitalization anchored around USD 160 million and analysts’ average price target at just USD 1.00, the equity market is signaling that Quantum-Si’s valuation remains tightly linked to its ability to convert its proteomics technology into sustained revenue progress over the coming quarters rather than to any near-term earnings visibility.MarketBeat

More news and analyses on Quantum-Si stock